A patient with a history of asthma is experiencing significant nocturnal symptoms and decreased peak expiratory flow rate, indicating a severe asthma exacerbation. Despite the use of a Fluticasone/Salmeterol inhaler, symptoms are not controlled. The healthcare team initiates systemic corticosteroids and nebulized bronchodilators. Which nursing intervention is most appropriate to ensure effective management of this patient's condition?

A) Encourage the patient to use a peak flow meter daily to monitor breathing function.

B) Teach the patient to increase the dose of Fluticasone/Salmeterol inhaler independently if symptoms persist.

C) Advise the patient to avoid all physical activity to prevent exacerbations.

D) Instruct the patient to discontinue systemic corticosteroids once symptoms improve.

A patient with asthma is experiencing increased nocturnal symptoms and a PEFR of 60% of her personal best. Her oxygen saturation intermittently drops to 89%. Which nursing intervention is the most appropriate to improve her gas exchange?

B) Administer prescribed systemic corticosteroids and nebulized bronchodilators promptly.

A) Encourage deep breathing exercises and monitor oxygen saturation closely.

B) Administer prescribed systemic corticosteroids and nebulized bronchodilators promptly.

C) Increase the frequency of Fluticasone/Salmeterol inhaler use to every 2 hours.

D) Advise the patient to rest in a supine position to conserve energy.

A patient with asthma is experiencing persistent dyspnea and wheezing despite treatment with systemic corticosteroids and nebulized bronchodilators. Her ABG results show respiratory acidosis with a pH of 7.32, PaCO2 of 52 mmHg, and PaO2 of 58 mmHg. Which nursing intervention is the priority to prevent progression to respiratory failure?

A) Administer supplemental oxygen to maintain oxygen saturation above 92%

B) Encourage the patient to perform incentive spirometry to improve lung expansion

C) Position the patient in a high Fowler's position to facilitate breathing

D) Administer intravenous magnesium sulfate as prescribed to relax bronchial muscles

A patient with asthma presents with persistent dyspnea and respiratory acidosis despite treatment with systemic corticosteroids and nebulized bronchodilators. Her ABG results show a pH of 7.32, PaCO2 of 52 mmHg, and PaO2 of 58 mmHg. Considering these findings, what is the most appropriate immediate nursing intervention to prevent further respiratory deterioration?

B) Administer supplemental oxygen to maintain oxygen saturation above 92%.

A) Increase the frequency of nebulized bronchodilator treatments.

B) Administer supplemental oxygen to maintain oxygen saturation above 92%.

C) Prepare for possible intubation and mechanical ventilation.

D) Encourage the patient to perform pursed-lip breathing and relaxation techniques.

A patient with asthma is receiving intravenous magnesium sulfate for respiratory distress. Despite treatment, her oxygen saturation remains borderline at 92% with supplemental oxygen. The chest X-ray shows mild hyperinflation, and the allergy panel indicates sensitivity to environmental allergens. What is the most appropriate nursing intervention to assist in stabilizing the patient's condition?

B) Educate the patient on proper inhaler technique to ensure effective medication delivery.

A) Increase the flow rate of supplemental oxygen to improve oxygen saturation.

B) Educate the patient on proper inhaler technique to ensure effective medication delivery.

C) Encourage the patient to rest in a supine position to improve respiratory function.

D) Prepare the patient for emergency intubation to address the respiratory distress.

A patient with asthma exacerbation has received intravenous magnesium sulfate, and diagnostic evaluations reveal high sensitivity to environmental allergens. What is the most appropriate nursing intervention to prioritize at this time?

C) Initiate a discussion with the patient about potential allergen exposure reduction strategies.

A) Educate the patient on the use of a peak flow meter to monitor asthma control.

B) Arrange for an immediate consultation with a pulmonologist to adjust medication regimens.

C) Initiate a discussion with the patient about potential allergen exposure reduction strategies.

D) Recommend increasing the dose of supplemental oxygen to improve oxygen saturation levels.

A patient with asthma exacerbation is experiencing increased respiratory distress and wheezing unresponsive to bronchodilators, a respiratory rate of 30 breaths per minute, and an oxygen saturation of 89% despite supplemental oxygen. The ABG analysis shows respiratory acidosis with a pH of 7.32 and PaCO2 of 50 mmHg. Which immediate nursing intervention is most appropriate to address the patient's current condition?

A) Increase the frequency of inhaled bronchodilator administration.

B) Prepare the patient for intubation and mechanical ventilation.

D) Administer systemic corticosteroids immediately.

A nurse is caring for a patient with acute asthma exacerbation who is experiencing increased respiratory distress, wheezing, and hypoxemia. Despite being on supplemental oxygen therapy, the patient's condition continues to worsen. An ABG analysis shows respiratory acidosis with a pH of 7.32 and a PaCO2 of 50 mmHg. What is the most appropriate nursing intervention at this time?

C) Prepare the patient for non-invasive positive pressure ventilation (NIPPV)

A) Increase the flow rate of supplemental oxygen

B) Administer a higher dose of bronchodilator

C) Prepare the patient for non-invasive positive pressure ventilation (NIPPV)

D) Initiate intravenous antibiotics

A patient with asthma is being treated with non-invasive positive pressure ventilation (NIPPV) and systemic corticosteroids but continues to experience wheezing and elevated PaCO2 levels. The healthcare team introduces a magnesium sulfate infusion. Which of the following nursing interventions is most critical to ensure the effectiveness of the magnesium sulfate treatment?

A) Monitor the patient's serum magnesium levels and report any abnormalities.

B) Educate the patient on the side effects of corticosteroids.

C) Administer bronchodilators before starting the magnesium sulfate infusion.

D) Adjust the NIPPV settings to increase the inspiratory pressure.

A patient with acute asthma exacerbation is being treated with non-invasive positive pressure ventilation (NIPPV) and systemic corticosteroids. Despite initial improvement in oxygenation, the patient remains tachycardic and anxious, with elevated PaCO2 levels. The healthcare team is considering additional interventions. Which nursing intervention is most appropriate to address the patient's current status?

B) Reassess and optimize NIPPV settings in collaboration with a respiratory therapist.

A) Increase the flow rate of supplemental oxygen.

B) Reassess and optimize NIPPV settings in collaboration with a respiratory therapist.

C) Administer a higher dose of intravenous corticosteroids.

D) Encourage the patient to perform deep breathing exercises to reduce anxiety.

Asthma - Nursing Case Study

Pathophysiology

• Primary mechanism: In asthma, chronic airway inflammation is driven by immune cells like eosinophils and T-helper 2 lymphocytes, leading to bronchial hyper-responsiveness. This causes the airways to constrict excessively in response to triggers like allergens, irritants, or exercise, resulting in wheezing and shortness of breath.

• Secondary mechanism: Smooth muscle hypertrophy and increased mucus production further narrow the airways. The thickened airway walls and excess mucus exacerbate obstruction, making it difficult for air to flow in and out of the lungs efficiently.

• Key complication: Persistent inflammation and repeated exacerbations can lead to airway remodeling, a structural change that reduces lung function over time and increases the risk of severe asthma attacks.

Patient Profile

Demographics:

45-year-old female, school teacher

History:

• Key past medical history: Asthma diagnosed at age 30, seasonal allergic rhinitis, mild hypertension

• Current medications: Albuterol inhaler as needed, Fluticasone/Salmeterol inhaler twice daily, Lisinopril 10 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increased shortness of breath and wheezing over the past week

• Key symptoms: Persistent cough, chest tightness, difficulty sleeping due to breathing issues, mild fatigue

• Vital signs: Blood pressure 145/92 mmHg, heart rate 105 bpm, respiratory rate 24 breaths per minute, oxygen saturation 92% on room air, temperature 98.6°F

Section 1

New Complications:

As the clinical team continues to monitor the patient's condition, it becomes evident that her asthma is not responding adequately to her current management plan. Despite regular use of her Fluticasone/Salmeterol inhaler, she experiences a significant increase in nocturnal symptoms, with frequent awakenings due to coughing and wheezing. Her oxygen saturation intermittently drops to 89% during these episodes, indicating worsening gas exchange. This prompts the healthcare team to reassess her treatment regimen and consider potential complications, such as asthma exacerbation or the development of status asthmaticus, a severe and prolonged asthma attack that does not respond to standard treatments.

Further investigation reveals that her peak expiratory flow rate (PEFR) has decreased to 60% of her personal best, highlighting a substantial decline in her pulmonary function. A spirometry test is ordered, which shows a reduced forced expiratory volume (FEV1) of 55% predicted, confirming the presence of moderate obstruction. Additionally, a chest X-ray is conducted to rule out other causes of her symptoms, such as pneumonia. The X-ray shows hyperinflation and the absence of acute infiltrates, supporting the diagnosis of a severe asthma exacerbation.

Given these findings, the clinical team decides to intensify her therapy. Systemic corticosteroids are initiated to address the acute inflammation, and nebulized bronchodilators are prescribed to improve bronchodilation. The patient is advised to avoid known triggers and is educated on the importance of adherence to her new treatment regimen. Follow-up is arranged to evaluate her response to the intensified treatment and to adjust her long-term management plan if necessary. This approach aims to stabilize her condition and prevent further complications, such as irreversible airway remodeling or a potentially life-threatening asthma attack.

Section 2

New Complications:

Despite the intensified treatment regimen, the patient's condition continues to show signs of complexity and progression. Two days after the initiation of systemic corticosteroids and nebulized bronchodilators, the patient reports persistent dyspnea and an increase in the frequency and severity of wheezing, particularly during physical activity. Her vital signs reveal a heart rate of 110 beats per minute, respiratory rate of 28 breaths per minute, and blood pressure of 135/85 mmHg. Her oxygen saturation remains unstable, fluctuating between 88% and 91% on room air, prompting the need for supplemental oxygen to maintain adequate saturation levels.

Following these observations, arterial blood gas (ABG) analysis is conducted to further evaluate her respiratory function and acid-base balance. The results indicate respiratory acidosis with a pH of 7.32, PaCO2 of 52 mmHg, and PaO2 of 58 mmHg, signifying hypoventilation and impaired gas exchange. This suggests that the patient is at risk of developing respiratory failure if her condition is not managed promptly and effectively. Additionally, serum eosinophil count is found to be elevated, supporting the presence of underlying inflammation that is resistant to current treatment protocols.

The clinical team is faced with the challenge of reassessing her management strategy and considering the introduction of additional therapies, such as intravenous magnesium sulfate or a trial of leukotriene receptor antagonists, to help alleviate her symptoms. They also explore the possibility of comorbid conditions, such as gastroesophageal reflux disease (GERD) or an undiagnosed allergy, which may be exacerbating her asthma. As they work to stabilize her respiratory status, the team emphasizes the need for close monitoring and rapid intervention to prevent further deterioration and potential progression to status asthmaticus.

Section 3

In response to the evolving complications, the clinical team decides to administer intravenous magnesium sulfate, given its role as a bronchodilator and ability to reduce airway inflammation. Over the next few hours, the patient experiences a modest improvement in her respiratory symptoms; her wheezing decreases in intensity, and she reports slightly less difficulty in breathing. Her vital signs show some stabilization, with her heart rate decreasing to 100 beats per minute and her respiratory rate dropping to 24 breaths per minute. However, her oxygen saturation remains borderline, hovering around 92% with supplemental oxygen. To ensure comprehensive management, the team decides to conduct further diagnostic evaluations, including a chest X-ray and a detailed allergy panel, to rule out any additional complicating factors.

The chest X-ray reveals mild hyperinflation but no evidence of pneumothorax or infection, suggesting that her current respiratory distress is primarily due to uncontrolled asthma. Meanwhile, the allergy panel indicates a high sensitivity to several common environmental allergens, such as dust mites and pollen, which could be contributing to her asthma exacerbations. This new information prompts the clinical team to consider the integration of an allergist for further evaluation and to possibly initiate allergen immunotherapy or enhanced environmental control measures to reduce triggers in her living environment.

As the team continues to monitor her response to the revised treatment plan, they emphasize the importance of educating the patient about trigger avoidance and adherence to her asthma action plan. They also discuss the potential need for a short-term course of leukotriene receptor antagonists to further address the underlying inflammatory processes. With these steps, the goal is to stabilize her condition, prevent progression to status asthmaticus, and lay the groundwork for long-term management strategies that address both her immediate and chronic needs.

Section 4

As the clinical team continues to monitor the patient's condition, they note a change in her status that requires immediate attention. Overnight, the patient begins to exhibit increasing respiratory distress, with a respiratory rate climbing back up to 30 breaths per minute and her oxygen saturation dropping to 89% despite being on a higher flow of supplemental oxygen. Her wheezing becomes more pronounced, and she reports a tightness in her chest that is not alleviated by her current bronchodilator regimen. The patient's heart rate remains elevated at 110 beats per minute, indicating persistent sympathetic activation due to respiratory compromise.

In response to these changes, the team conducts an arterial blood gas (ABG) analysis which reveals a respiratory acidosis with a pH of 7.32 and a partial pressure of carbon dioxide (PaCO2) of 50 mmHg. These findings suggest that the patient's respiratory muscles are beginning to fatigue, leading to hypoventilation and CO2 retention. The team recognizes the urgency of preventing further deterioration and considers the potential need for non-invasive positive pressure ventilation (NIPPV) to support her breathing and improve gas exchange. Concurrently, they evaluate the effectiveness of the current medication regimen and contemplate the necessity of introducing systemic corticosteroids to rapidly reduce airway inflammation.

The clinical reasoning process involves reassessing the balance of pharmacologic and non-pharmacologic interventions to stabilize her condition. The team emphasizes the need for continuous monitoring and readiness to escalate care, should the patient show signs of progressing towards status asthmaticus. Additionally, they ensure that the patient and her family are informed about the critical nature of her condition and the steps being taken to manage it effectively. Through these actions, the team aims to reverse the acute exacerbation while setting the stage for a long-term asthma management plan that minimizes future risks and improves her overall quality of life.

Section 5

As the clinical team adjusts the patient's treatment plan, they initiate non-invasive positive pressure ventilation (NIPPV) to support her breathing. Within the first hour of using NIPPV, the patient's respiratory rate decreases to 24 breaths per minute, and her oxygen saturation improves to 93%. However, the wheezing persists, and she continues to experience chest tightness. Recognizing the need to target the underlying inflammation, the team administers a dose of intravenous systemic corticosteroids, aiming to reduce airway swelling more effectively.

Shortly after these interventions, the team observes a significant change in the patient's status. Although her oxygenation shows improvement, her heart rate remains elevated at 108 beats per minute, and she begins to exhibit signs of anxiety and restlessness. A repeat arterial blood gas analysis indicates a slight improvement in pH to 7.34, but the PaCO2 remains elevated at 48 mmHg, highlighting ongoing respiratory compromise. These findings suggest that while the initial interventions have provided some relief, further adjustments to her treatment plan are necessary to address the persistent ventilation issues.

The team decides to introduce a magnesium sulfate infusion, a bronchodilator that can help reduce muscle constriction in the airways, in hopes of breaking the cycle of bronchospasm and allowing for better ventilation. They also consider consulting with a respiratory therapist to optimize the settings on the NIPPV device, ensuring maximal effectiveness. With these steps, the clinical team aims to stabilize the patient further and prevent progression to status asthmaticus, while also preparing to initiate discussions about long-term management strategies to prevent future exacerbations. Through continued vigilance and adaptive management, they seek to guide the patient toward recovery.